Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDICAMEQ Medicamen Biotech Limited Pharma · Small | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | BROOKS Brooks Laboratories Limited Pharma · Small | ALPA Alpa Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 19 | 15 | 69 | 46 |
| Verdict | OVERVALUED | OVERVALUED | UNDERVALUED | FAIR VALUE |
| Style | OVERVALUED | OVERVALUED | Deep Value | Deep Value |
| Piotroski | 5/9 | 6/9 | 8/9 | 6/9 |
| Valuation | 4/30 | 3/30 | 27/30 | 26/30 |
| Growth | 5/25 | 2/25 | 18/25 | 11/25 |
| Quality | 0/20 | 0/20 | 13/20 | 0/20 |
| Balance Sheet | 9/15 | 6/15 | 11/15 | 10/15 |
| Cash Flow | 0/10 | 4/10 | 3/10 | 4/10 |
| Price | ₹239.75 | ₹80.24 | ₹68.23 | ₹69.36 |
| P/E | 31.40 | 55.60 | 7.99 | 9.57 |
| P/B | 1.10 | 1.47 | 1.60 | 0.77 |
| ROE | 3.95% | 2.75% | 22.30% | 8.39% |
| ROCE | 5.43% | 5.58% | 21.50% | 9.42% |
| Debt / Equity | 0.17 | 0.33 | 0.07 | 0.02 |
| FCF Yield | — | — | 3.06% | — |
| Dividend Y | 0.45% | — | — | — |
| Altman Z | 3.86 | 3.33 | 6.44 | 3.25 |
| Promoter % | 40.46% | 37.71% | 52.62% | 57.19% |
| Mkt Cap (₹Cr) | 303.00 | 221.00 | 196.00 | 144.00 |
| Graham # | ₹180.21 | ₹40.86 | ₹88.35 | ₹119.15 |
| Fair PE | 5.8 | 4.2 | 42.0 | 42.0 |
| MoS % | -483.4% | -1261.3% | +80.5% | +76.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDICAMEQ47
AAREYDRUGS125
BROOKS49
ALPA61